Biotech · Private company
AbCellera Biologics Inc.
Track this companyFree. Adds AbCellera Biologics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)PHASE2 · COMPLETED · started Feb 1, 2021ClinicalTrials.gov NCT04701658 · fetched Nov 12, 2026
- A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 IllnessPHASE2 · COMPLETED · started Oct 29, 2020ClinicalTrials.gov NCT04634409 · fetched Nov 12, 2026
- A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and StaffPHASE3 · COMPLETED · started Aug 2, 2020ClinicalTrials.gov NCT04497987 · fetched Nov 12, 2026
- A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 IllnessPHASE2_PHASE3 · COMPLETED · started Jun 17, 2020ClinicalTrials.gov NCT04427501 · fetched Nov 12, 2026
- A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19PHASE1 · COMPLETED · started May 28, 2020ClinicalTrials.gov NCT04411628 · fetched Nov 12, 2026